W Wurst

1.9k total citations
56 papers, 1.5k citations indexed

About

W Wurst is a scholar working on Oncology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W Wurst has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Pharmacology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W Wurst's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Gastroesophageal reflux and treatments (10 papers). W Wurst is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Gastroesophageal reflux and treatments (10 papers). W Wurst collaborates with scholars based in Germany, United States and Austria. W Wurst's co-authors include M. Hartmann, H Bliesath, Reinhard Huber, Anton Drollmann, V W Steinijans, Thomas D. Bethke, Hartmut Derendorf, Reinhold Lühmann, R. Nave and Franklin Cerasoli and has published in prestigious journals such as Gastroenterology, The Journal of Clinical Endocrinology & Metabolism and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

W Wurst

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Wurst Germany 23 758 478 454 419 237 56 1.5k
Staffan Edsbäcker Sweden 24 856 1.1× 231 0.5× 75 0.2× 812 1.9× 88 0.4× 41 1.6k
R P Walt United Kingdom 26 476 0.6× 1.5k 3.1× 1.2k 2.6× 111 0.3× 186 0.8× 65 2.3k
M. Lazzaroni Italy 21 313 0.4× 966 2.0× 567 1.2× 117 0.3× 104 0.4× 78 1.5k
Mark Sostek United States 24 407 0.5× 1.5k 3.1× 1.7k 3.7× 251 0.6× 101 0.4× 71 2.4k
Jean Spénard Canada 15 171 0.2× 428 0.9× 194 0.4× 70 0.2× 69 0.3× 45 971
S P Wilkinson United Kingdom 23 425 0.6× 531 1.1× 67 0.1× 146 0.3× 236 1.0× 52 1.8k
Su Youn Nam South Korea 27 595 0.8× 1.1k 2.3× 495 1.1× 187 0.4× 222 0.9× 115 1.8k
Wolfgang Timmer Germany 17 408 0.5× 129 0.3× 36 0.1× 465 1.1× 169 0.7× 32 908
K W Somerville United Kingdom 17 149 0.2× 580 1.2× 218 0.5× 76 0.2× 93 0.4× 25 1.3k
Richard G. Fiddian-Green United States 19 657 0.9× 1.4k 2.9× 329 0.7× 109 0.3× 109 0.5× 43 2.2k

Countries citing papers authored by W Wurst

Since Specialization
Citations

This map shows the geographic impact of W Wurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Wurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Wurst more than expected).

Fields of papers citing papers by W Wurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Wurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Wurst. The network helps show where W Wurst may publish in the future.

Co-authorship network of co-authors of W Wurst

This figure shows the co-authorship network connecting the top 25 collaborators of W Wurst. A scholar is included among the top collaborators of W Wurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Wurst. W Wurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taut, Friedemann, Gerd Rippin, Peter Schenk, et al.. (2008). A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy. CHEST Journal. 134(4). 724–732. 68 indexed citations
2.
Bethke, Thomas D., Róbert Hermann, Bernhard Hauns, et al.. (2006). Dose‐Proportional Intraindividual Single‐ and Repeated‐Dose Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor. The Journal of Clinical Pharmacology. 47(1). 26–36. 75 indexed citations
3.
Leach, Chet, Thomas D. Bethke, Robert J. Boudreau, et al.. (2006). Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy Volunteers. Journal of Aerosol Medicine. 19(2). 117–126. 76 indexed citations
4.
Derendorf, Hartmut, R. Nave, Anton Drollmann, Franklin Cerasoli, & W Wurst. (2006). Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. European Respiratory Journal. 28(5). 1042–1050. 188 indexed citations
5.
Spragg, Roger G., James F. Lewis, W Wurst, et al.. (2003). Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant. American Journal of Respiratory and Critical Care Medicine. 167(11). 1562–1566. 127 indexed citations
6.
Hartmann, M., et al.. (2003). Intragastric Ph During Continuous Infusion With Pantoprazole in Patients With Bleeding Peptic Ulcer. The American Journal of Gastroenterology. 98(12). 2635–2641. 54 indexed citations
7.
Schmidt, Bernhard M. W., et al.. (1999). The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis. The Journal of Clinical Pharmacology. 39(10). 1062–1069. 36 indexed citations
8.
Horák, Jiří, et al.. (1998). Pantoprazole in patients with varying degree of liver impairment in comparison to heal thy controls. Gastroenterology. 114. A6–A6. 4 indexed citations
9.
Huber, Reinhard, H Bliesath, M. Hartmann, et al.. (1998). Pantoprazole does not interact with the pharmacokinetics of carbamazepine.. PubMed. 36(10). 521–4. 16 indexed citations
10.
Kaps, Manfred, et al.. (1997). Transcranial Doppler echo contrast studies using different colour processing modes. Acta Neurologica Scandinavica. 95(6). 358–362. 1 indexed citations
11.
Fuder, H., M. Hartmann, Wolfgang Timmer, et al.. (1996). Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. European Journal of Clinical Pharmacology. 51(3-4). 277–281. 18 indexed citations
12.
Gugler, R, M. Hartmann, Reinhard Huber, et al.. (1996). Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. British Journal of Clinical Pharmacology. 42(2). 249–252. 33 indexed citations
13.
Ukena, D., et al.. (1995). Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial. Cancer Chemotherapy and Pharmacology. 36(2). 160–164. 5 indexed citations
14.
Belz, G. G., et al.. (1992). Differential effects of two dihydropyridine calcium antagonists in humans. Clinical Pharmacology & Therapeutics. 52(1). 68–79. 4 indexed citations
15.
16.
Zitta, Sabine, et al.. (1990). Pharmacokinetics of Urapidil in Patients with Impaired Renal Function. Drugs. 40(Supplement 4). 67–68. 1 indexed citations
17.
Simon, Bernd, Peter Müller, Reinhold Lühmann, et al.. (1990). Effect of repeated oral administration of BY 1023/SK&F 96022 – a new substituted benzimidazole derivative – on pentagastrin‐stimulated gastric acid secretion and pharmacokinetics in man. Alimentary Pharmacology & Therapeutics. 4(4). 373–379. 39 indexed citations
18.
Cazzola, Mario, Alberto Spinazzi, G Santangelo, et al.. (1990). Acute Effects of Urapidil on Airway Response in Hypertensive Patients with Chronic Obstructive Pulmonary Disease. Drugs. 40(Supplement 4). 71–72. 9 indexed citations
19.
Wurst, W, et al.. (1989). Overview of clinical trials with urapidil. The American Journal of Cardiology. 64(7). D30–D37. 5 indexed citations
20.
Wurst, W, et al.. (1989). Effect of urapidil on steady-state serum digoxin concentration in healthy subjects. European Journal of Clinical Pharmacology. 37(2). 193–194. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Staffan Edsbäcker Breakdown of academic impact, for papers by R P Walt Breakdown of academic impact, for papers by M. Lazzaroni Breakdown of academic impact, for papers by Mark Sostek Breakdown of academic impact, for papers by Jean Spénard Breakdown of academic impact, for papers by S P Wilkinson Breakdown of academic impact, for papers by Su Youn Nam Breakdown of academic impact, for papers by Wolfgang Timmer Breakdown of academic impact, for papers by K W Somerville Breakdown of academic impact, for papers by Richard G. Fiddian-Green
Rankless by CCL
2026